PNC Financial Services Group
AMPH icon

PNC Financial Services Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

PNC Financial Services Group’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$107K Sell
5,449
-359
-6% -$8.78K ﹤0.01% 2772
2025
Q4 		$156K Buy
5,808
+277
+5% +$7.13K ﹤0.01% 2476
2025
Q3 		$147K Sell
5,531
-952
-15% -$24.6K ﹤0.01% 2516
2025
Q2 		$149K Buy
6,483
+1,700
+36% +$42.2K ﹤0.01% 2419
2025
Q1 		$139K Buy
4,783
+580
+14% +$18.5K ﹤0.01% 2436
2024
Q4 		$156K Buy
4,203
+1,992
+90% +$91.1K ﹤0.01% 2384
2024
Q3 		$107K Buy
2,211
+58
+3% +$2.54K ﹤0.01% 2632
2024
Q2 		$86.1K Sell
2,153
-4,489
-68% -$186K ﹤0.01% 2711
2024
Q1 		$292K Buy
6,642
+4,394
+195% +$227K ﹤0.01% 1907
2023
Q4 		$139K Sell
2,248
-219
-9% -$11.5K ﹤0.01% 2396
2023
Q3 		$113K Buy
2,467
+59
+2% +$3.22K ﹤0.01% 2495
2023
Q2 		$138K Buy
2,408
+128
+6% +$5.67K ﹤0.01% 2446
2023
Q1 		$85.5K Sell
2,280
-96
-4% -$3.15K ﹤0.01% 2662
2022
Q4 		$66.6K Sell
2,376
-487
-17% -$14.1K ﹤0.01% 2809
2022
Q3 		$80K Buy
2,863
+841
+42% +$27.5K ﹤0.01% 2684
2022
Q2 		$70K Buy
2,022
+5
+0.2% +$178 ﹤0.01% 2792
2022
Q1 		$73K Buy
2,017
+81
+4% +$2.3K ﹤0.01% 2890
2021
Q4 		$44K Sell
1,936
-215
-10% -$4.4K ﹤0.01% 3174
2021
Q3 		$41K Sell
2,151
-136
-6% -$2.66K ﹤0.01% 3175
2021
Q2 		$47K Sell
2,287
-434
-16% -$8.18K ﹤0.01% 3097
2021
Q1 		$49K Buy
2,721
+377
+16% +$7.01K ﹤0.01% 2985
2020
Q4 		$48K Buy
2,344
+271
+13% +$5.27K ﹤0.01% 2915
2020
Q3 		$40K Buy
2,073
+101
+5% +$2.03K ﹤0.01% 2861
2020
Q2 		$44K Sell
1,972
-49
-2% -$897 ﹤0.01% 2824
2020
Q1 		$30K Sell
2,021
-704
-26% -$12.2K ﹤0.01% 2905
2019
Q4 		$52K Buy
2,725
+316
+13% +$6.06K ﹤0.01% 2867
2019
Q3 		$48K Buy
2,409
+96
+4% +$2K ﹤0.01% 2925
2019
Q2 		$50K Buy
2,313
+51
+2% +$1.07K ﹤0.01% 2936
2019
Q1 		$45K Buy
2,262
+82
+4% +$1.84K ﹤0.01% 2997
2018
Q4 		$42K Buy
2,180
+395
+22% +$7.79K ﹤0.01% 2963
2018
Q3 		$34K Buy
1,785
+1,050
+143% +$18.7K ﹤0.01% 3222
2018
Q2 		$13K Sell
735
-664
-47% -$11.6K ﹤0.01% 3591
2018
Q1 		$26K Sell
1,399
-23
-2% -$432 ﹤0.01% 3292
2017
Q4 		$27K Buy
1,422
+1,028
+261% +$19.2K ﹤0.01% 3250
2017
Q3 		$7K Sell
394
-60,127
-99% -$989K ﹤0.01% 3781
2017
Q2 		$1.08M Sell
60,521
-90
-0.1% -$1.43K ﹤0.01% 1243
2017
Q1 		$880K Sell
60,611
-54,359
-47% -$855K ﹤0.01% 1348
2016
Q4 		$2.12M Sell
114,970
-2,422
-2% -$47.1K ﹤0.01% 970
2016
Q3 		$2.23M Buy
117,392
+117,288
+112,777% +$2.13M ﹤0.01% 937
2016
Q2 		$2K Sell
104
-4
-4% -$56 ﹤0.01% 4123
2016
Q1 		$1K Buy
108
+4
+4% +$47 ﹤0.01% 4337
2015
Q4 		$1K Hold
104
– – ﹤0.01% 4300
2015
Q3 		$1K Buy
104
+3
+3% +$45 ﹤0.01% 4433
2015
Q2 		$2K Buy
+101
New +$1.57K ﹤0.01% 4363

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

PNC Financial Services Group's AMPH Position: Q1 2026 in Review

PNC Financial Services Group reduced its Amphastar Pharmaceuticals (AMPH) stake by 6.2% in Q1 2026, selling an estimated $8.78K and leaving 5,449 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #2772.

PNC Financial Services Group first reported a position in AMPH in Q2 2015 and has held it in 44 quarters since. The position peaked at $2.23M in Q3 2016. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • PNC Financial Services Group held 5,449 shares of Amphastar Pharmaceuticals worth $107K as of Q1 2026.
  • PNC Financial Services Group sold 359 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $8.78K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #2772 holding.
  • PNC Financial Services Group first reported a position in Amphastar Pharmaceuticals in Q2 2015 and has held it in 44 quarters since.
  • PNC Financial Services Group's Amphastar Pharmaceuticals position peaked at $2.23M in Q3 2016.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.